Risk of malignancy in pulmonary nodules: A validation study of four prediction models
- PMID: 25864782
- DOI: 10.1016/j.lungcan.2015.03.018
Risk of malignancy in pulmonary nodules: A validation study of four prediction models
Abstract
Objectives: Clinical prediction models assess the likelihood of malignancy in pulmonary nodules detected by computed tomography (CT). This study aimed to validate four such models in a UK population of patients with pulmonary nodules. Three models used clinical and CT characteristics to predict risk (Mayo Clinic, Veterans Association, Brock University) with a fourth model (Herder et al. [4]) additionally incorporating (18)Fluorine-Fluorodeoxyglucose (FDG) avidity on positron emission tomography-computed tomography (PET-CT).
Materials and methods: The likelihood of malignancy was calculated for patients with pulmonary nodules (4-30mm diameter) and data used to calculate the area under the receiver operating characteristic curve (AUC) for each model. The models were used in a restricted cohort of patients based on each model's exclusion criteria and in the total cohort of all patients.
Results: Two hundred and forty-four patients were studied, of whom 139 underwent FDG PET-CT. Ninety-nine (40.6%) patients were subsequently confirmed to have malignant nodules (33.2% primary lung cancer, 7.4% metastatic disease). The Mayo and Brock models performed similarly (AUC 0.895 and 0.902 respectively) and both were significantly better than the Veterans Association model (AUC 0.735, p<0.001 and p=0.002 respectively). In patients undergoing FDG PET-CT, the Herder model had significantly higher accuracy than the other three models (AUC 0.924). When the models were tested on all patients in the cohort (i.e. including those outside the original model inclusion criteria) AUC values were reduced, yet remained high especially for the Herder model (AUC 0.916). For sub-centimetre nodules, AUC values for the Mayo and Brock models were 0.788 and 0.852 respectively.
Conclusions: The Mayo and Brock models showed good accuracy for determining likelihood of malignancy in nodules detected on CT scan. In patients undergoing FDG PET-CT for nodule evaluation, the highest accuracy was seen for the model described by Herder et al. incorporating FDG avidity.
Keywords: AUC values; FDG PET–CT; Lung cancer; Multiple pulmonary nodules; Prediction models; Solitary pulmonary nodule.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.AJR Am J Roentgenol. 2014 Mar;202(3):507-14. doi: 10.2214/AJR.13.11728. AJR Am J Roentgenol. 2014. PMID: 24555586
-
Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT.Radiology. 2015 Feb;274(2):563-75. doi: 10.1148/radiol.14132289. Epub 2014 Sep 8. Radiology. 2015. PMID: 25203128
-
Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults.PLoS One. 2018 Jul 31;13(7):e0201242. doi: 10.1371/journal.pone.0201242. eCollection 2018. PLoS One. 2018. PMID: 30063725 Free PMC article.
-
LUCIS: lung cancer imaging studies.Dan Med J. 2012 Nov;59(11):B4542. Dan Med J. 2012. PMID: 23171752 Review.
-
What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?Zentralbl Chir. 2014 Feb;139(1):108-13. doi: 10.1055/s-0033-1360182. Epub 2014 Feb 28. Zentralbl Chir. 2014. PMID: 24585199 Review.
Cited by
-
Lung nodules: A comprehensive review on current approach and management.Ann Thorac Med. 2019 Oct-Dec;14(4):226-238. doi: 10.4103/atm.ATM_110_19. Ann Thorac Med. 2019. PMID: 31620206 Free PMC article. Review.
-
Comparison of prediction models with radiological semantic features and radiomics in lung cancer diagnosis of the pulmonary nodules: a case-control study.Eur Radiol. 2019 Nov;29(11):6100-6108. doi: 10.1007/s00330-019-06213-9. Epub 2019 May 21. Eur Radiol. 2019. PMID: 31115618 Free PMC article.
-
Malignancy risk stratification for pulmonary nodules: comparing a deep learning approach to multiparametric statistical models in different disease groups.Eur Radiol. 2025 Jul;35(7):3812-3822. doi: 10.1007/s00330-024-11256-8. Epub 2025 Jan 2. Eur Radiol. 2025. PMID: 39747589 Free PMC article.
-
Multicentre external validation of the BIMC model for solid solitary pulmonary nodule malignancy prediction.Eur Radiol. 2017 May;27(5):1929-1933. doi: 10.1007/s00330-016-4538-5. Epub 2016 Aug 23. Eur Radiol. 2017. PMID: 27553937
-
The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules.Dis Markers. 2021 Feb 18;2021:6677823. doi: 10.1155/2021/6677823. eCollection 2021. Dis Markers. 2021. PMID: 33688380 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical